DCM
BIIB icon

Discovery Capital Management’s Biogen BIIB Stock Holding History

Discovery Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-504,765
Closed -$143M – 96
2016
Q4 		$143M Buy
504,765
+407,465
+419% +$121M 2.41% 10
2016
Q3 		$30.5M Buy
+97,300
New +$28.8M 0.65% 45
2015
Q4 		– Sell
-697,880
Closed -$204M – 98
2015
Q3 		$204M Buy
+697,880
New +$230M 2.26% 13

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Discovery Capital Management's BIIB Position: Q1 2017 in Review

Discovery Capital Management sold out of Biogen (BIIB) in Q1 2017, closing a stake of 504,765 shares — an estimated $143M sold.

Discovery Capital Management first reported a position in BIIB in Q3 2015 and held it in 3 quarters. The position peaked at $204M in Q3 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

  • Discovery Capital Management reported no remaining Biogen position as of Q1 2017 after selling out during the quarter.
  • Discovery Capital Management sold 504,765 Biogen shares in Q1 2017, an estimated $143M.
  • Discovery Capital Management first reported a position in Biogen in Q3 2015 and held it in 3 quarters.
  • Discovery Capital Management's Biogen position peaked at $204M in Q3 2015.
  • 1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Discovery Capital Management's 13F filing for Q1 2017, filed 15 May 2017.